作者：
Saura,C. [1]
;
Bendell,J. [2]
;
Jerusalem,G. [3]
;
Su,S. [4]
;
Ru,Q. [5]
;
DeBuck,S. [6]
;
Mills,D. [7]
;
Ruquet,S. [8]
;
Bosch,A. [9]
;
Urruticoechea,A. [10]
;
Beck,J.T. [11]
;
DiTomaso,E. [12]
;
Sternberg,D.W. ;
Massacesi,C. ;
Hirawat,S. ;
Dirix,L. ;
Baselga,J.
作者单位：
Highlands Oncology Group, Fayetteville, AR, United States
[1]
Novartis Institutes for BioMedical Research, Cambridge, MA, United States
[2]
Sarah Cannon Research Institute, Nashville, TN, United States
[3]
Novartis Oncology, Paris, France
[4]
Catalan Institute of Oncology, Barcelona, Spain
[5]
C.H.U. Sart-Tilman, Liege, Belgium
[6]
Novartis Pharmaceuticals, East Hanover, NJ, United States
[7]
Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology
[8]
Oncologisch Centrum AZ-St. Augustinus Oncology, Antwerp, Belgium
[9]
Memorial Sloan - Kettering Cancer Centre, New York, NY, United States
[10]
Novartis Pharma AG, Basel, Switzerland
[11]
Novartis Pharmaceuticals, Florham Park, NJ, United States
[12]
发布时间
2014-11-28
换一批
